Precision BioSciences (DTIL) Insider Trading & Ownership $4.13 -0.45 (-9.83%) (As of 04:00 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Precision BioSciences (NASDAQ:DTIL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$113,740.03 Get DTIL Insider Trade Alerts Want to know when executives and insiders are buying or selling Precision BioSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DTIL Insider Buying and Selling by Quarter Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Precision BioSciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/4/2024Michael AmorosoCEOSell3,012$8.19$24,668.28 6/10/2024Dario ScimecaGeneral CounselSell93$11.79$1,096.47 6/10/2024J. Jefferson SmithInsiderSell50$11.79$589.50 5/2/2024Dario ScimecaGeneral CounselSell272$10.32$2,807.04 5/2/2024J. Jefferson SmithInsiderSell154$10.32$1,589.28 5/2/2024Michael AmorosoCEOSell1,526$10.32$15,748.32 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/30/2024Alan ListInsiderSell238$10.03$2,387.14 1/22/2024Alan ListInsiderSell717$10.80$7,743.60 1/22/2024Dario ScimecaGeneral CounselSell709$10.80$7,657.20 1/22/2024Michael AmorosoCEOSell4,579$10.80$49,453.20 (Data available from 1/1/2013 forward) DTIL Insider Trading Activity - Frequently Asked Questions Who is on Precision BioSciences's Insider Roster? The list of insiders at Precision BioSciences includes Alan List, Dario Scimeca, Derek Jantz, J. Jefferson Smith, John Alexander Kelly, and Michael Amoroso. Learn more on insiders at DTIL. What percentage of Precision BioSciences stock is owned by insiders? 4.00% of Precision BioSciences stock is owned by insiders. Learn more on DTIL's insider holdings. Which Precision BioSciences insiders have been buying company stock? The following insider purchased DTIL shares in the last 24 months: John Alexander Kelly ($17,182.80). How much insider buying is happening at Precision BioSciences? Insiders have purchased a total of 666 DTIL shares in the last 24 months for a total of $17,182.80 bought. Which Precision BioSciences insiders have been selling company stock? The following insiders have sold DTIL shares in the last 24 months: Alan List ($26,380.54), Dario Scimeca ($30,969.21), J. Jefferson Smith ($2,178.78), and Michael Amoroso ($178,397.40). How much insider selling is happening at Precision BioSciences? Insiders have sold a total of 18,596 Precision BioSciences shares in the last 24 months for a total of $237,925.93 sold. Precision BioSciences Key ExecutivesMr. Michael Amoroso (Age 46)President, CEO & Director Compensation: $1.07M1 recent tradesMr. John Alexander Kelly R.Ph. (Age 57)CFO & Principal Accounting Officer Compensation: $660.91kDr. Alan F. List M.D. (Age 69)Chief Medical Officer Compensation: $692.17kDr. Jefferson J. Smith Ph.D. (Age 51)Co-Founder & Chief Research Officer Mei BurrisDirector of Investor Relations & FinanceMr. Dario Scimeca (Age 49)General Counsel & Secretary Compensation: $576.43kMr. Bruce StevensVice President of Quality & ComplianceMaurissa MessierSenior Director of Corporate CommunicationsMs. Juli BlancheChief People OfficerMr. Garrett GincleyHead of Manufacturing More Insider Trading Tools from MarketBeat Related Companies FitLife Brands Insider Trades Adaptimmune Therapeutics Insider Trades Puma Biotechnology Insider Trades Elutia Insider Trades Black Diamond Therapeutics Insider Trades Galectin Therapeutics Insider Trades Monopar Therapeutics Insider Trades Atossa Therapeutics Insider Trades Enanta Pharmaceuticals Insider Trades Cabaletta Bio Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:DTIL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.